Peptides  ›  Ipamorelin  ›  Growth Hormone
Growth Hormone

Ipamorelin for Growth Hormone: What the Research Says

Preclinical and early human pharmacology research.Updated August 2026

Ipamorelin (also known as Growth hormone secretagogue) is a selective growth-hormone secretagogue studied for its clean GH-release profile. This page covers what the published research does — and does not — establish about it in relation to growth-hormone support.

What the research covers

Ipamorelin is researched for Growth hormone release — which is why it appears in discussions of growth-hormone support.

Research status: Preclinical and early human pharmacology research.

How Ipamorelin is thought to work

Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin at its receptor to trigger growth-hormone release. It is valued in research for a relatively "clean" profile, with less effect on appetite, cortisol, and prolactin than some older secretagogues.

What it does not establish

Endocrine-active. Not an approved medication for these uses.

Nothing on this page is a recommendation to use Ipamorelin, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.

Commonly researched alongside

A growth-hormone-releasing hormone analog studied for GH support.

Other peptides researched for Growth Hormone

A growth-hormone-releasing hormone analog studied for GH support.

One of the earliest GHRH analogs, historically used to assess GH function.

A GHRH analog approved for HIV-associated lipodystrophy and studied for visceral fat.

A growth-hormone-releasing peptide studied as a GH secretagogue.

An early GH-releasing peptide known for strongly stimulating appetite.

A potent GH secretagogue also studied for cardiac tissue effects.

An orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1.

Frequently asked questions

Preclinical and early human pharmacology research. Research relevant to this area covers growth hormone release. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.

Preclinical and early human pharmacology research.

Endocrine-active. Not an approved medication for these uses. Always speak to a licensed healthcare professional before considering any peptide.

Stimulating growth-hormone release, with interest in recovery and body composition. It is often paired with a GHRH analog like CJC-1295.

Compared with earlier secretagogues, it tends to raise growth hormone with fewer off-target effects on cortisol, prolactin, and hunger in studies.

Is Ipamorelin right for your situation?

Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.

Ask the Advisor — free

This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.